Tenet critic dissolves shareholder group; DTC advertising falling out of favor?;

> A vocal Tenet Healthcare critic has dissolved a shareholders' group designed to serve as a watchdog over the company. FierceHealthFinance

> Will direct-to-consumer pharma marketing lose its popularity in 2009? Some observers think so, citing critical statements by pharma leaders and moves to back off from DTC spending. Article

> Merck is reporting that due to equipment upgrades at a Pennsylvania plant, it will experience shortages of its hepatitis B vaccine Recombivax for adults. FierceVaccines

> Research advocates have hit the Massachusetts Congressional delegation hard in an effort to get larger NIH grants included proposed economic stimulus package. FierceBioResearcher

And Finally... Now this has got to be the oddest map I've ever heard of--I mean, who would use it? Article